Gilead Sciences, Inc. (TSX:GILD)
Canada flag Canada · Delayed Price · Currency is CAD
31.92
+0.51 (1.62%)
Oct 26, 2026, 3:49 PM EDT

Gilead Sciences Revenue

Gilead Sciences had revenue of $7.80B USD in the quarter ending June 30, 2026, with 10.18% growth. This brings the company's total for the last twelve months to $30.46B, up 5.52% year-over-year. In the year 2025, Gilead Sciences had annual revenue of $29.44B with 2.40% growth.

Revenue (ttm)
$30.46B
Revenue Growth
+5.52%
P/S Ratio
6.38
Revenue / Employee
$1.79M
Employees
17,000
Market Cap
275.86B CAD

Revenue Chart

* This company reports financials in USD.

Revenue by Segment

By Segment

Chart
  • Product Sales 28.92B 98.2%
  • Royalty, Contract and Other 527.00M 1.8%

By Geography

  • United States 20.88B 70.9%
  • Europe 5.06B 17.2%
  • Rest of World 3.50B 11.9%
Fiscal year ended Dec 31, 2025 See the full Gilead Sciences breakdown

Revenue History

Fiscal Year EndRevenueChangeGrowth
Dec 31, 202529.44B689.00M2.40%
Dec 31, 202428.75B1.64B6.04%
Dec 31, 202327.12B-165.00M-0.60%
Dec 31, 202227.28B-24.00M-0.09%
Dec 31, 202127.31B2.62B10.60%
Dec 31, 202024.69B2.24B9.98%
Dec 31, 201922.45B322.00M1.46%
Dec 31, 201822.13B-3.98B-15.24%
Dec 31, 201726.11B-4.28B-14.09%
Dec 31, 201630.39B-2.25B-6.89%
Dec 31, 201532.64B7.75B31.13%
Dec 31, 201424.89B13.69B122.19%
Dec 31, 201311.20B1.50B15.46%
Dec 31, 20129.70B1.32B15.70%
Dec 31, 20118.39B435.97M5.48%
Dec 31, 20107.95B938.04M13.38%
Dec 31, 20097.01B1.68B31.40%
Dec 31, 20085.34B1.11B26.14%
Dec 31, 20074.23B1.20B39.78%
Dec 31, 20063.03B997.74M49.19%
Dec 31, 20052.03B--